226 related articles for article (PubMed ID: 22706483)
21. Targeted therapy in lung cancer: survival, quality of life improved for some patients.
Printz C
Cancer; 2014 Sep; 120(17):2625-6. PubMed ID: 25142921
[No Abstract] [Full Text] [Related]
22. Current drugs and drug targets in non-small cell lung cancer: limitations and opportunities.
Daga A; Ansari A; Patel S; Mirza S; Rawal R; Umrania V
Asian Pac J Cancer Prev; 2015; 16(10):4147-56. PubMed ID: 26028064
[TBL] [Abstract][Full Text] [Related]
23. Emerging drugs for squamous cell lung cancer.
Cheng H; Shcherba M; Kandavelou K; Liang Y; Liu H; Perez-Soler R
Expert Opin Emerg Drugs; 2015 Mar; 20(1):149-60. PubMed ID: 25557559
[TBL] [Abstract][Full Text] [Related]
24. Three cheers for targeted therapy in non-small cell lung cancer... When we hit the target!
Codacci-Pisanelli G; Frati L; Mini E
J Chemother; 2011 Aug; 23(4):245-6. PubMed ID: 21803707
[No Abstract] [Full Text] [Related]
25. Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?
Remon J; Hendriks LE; Cabrera C; Reguart N; Besse B
Cancer Treat Rev; 2018 Dec; 71():47-58. PubMed ID: 30359792
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapy for NSCLC with driver mutations.
Minuti G; D'Incecco A; Cappuzzo F
Expert Opin Biol Ther; 2013 Oct; 13(10):1401-12. PubMed ID: 23930754
[TBL] [Abstract][Full Text] [Related]
27. ROS1 gene rearrangement is identified in NSCLC.
Cancer Discov; 2012 Feb; 2(2):OF9. PubMed ID: 22585869
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy.
Biello F; Burrafato G; Rijavec E; Genova C; Barletta G; Truini A; Coco S; Bello MG; Alama A; Boccardo F; Grossi F
Anticancer Agents Med Chem; 2016; 16(9):1142-54. PubMed ID: 26845137
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers and molecular profiling in non-small cell lung cancer: an expanding role and its managed care implications.
Adamson RT
Am J Manag Care; 2013 Dec; 19(19 Suppl):s398-404. PubMed ID: 24494721
[TBL] [Abstract][Full Text] [Related]
30. ROS1 Targeted Therapies: Current Status.
Azelby CM; Sakamoto MR; Bowles DW
Curr Oncol Rep; 2021 Jun; 23(8):94. PubMed ID: 34125313
[TBL] [Abstract][Full Text] [Related]
31. Emerging targeted therapies in non-small cell lung cancer.
Khanal N; Ganti AK
Expert Rev Anticancer Ther; 2016; 16(2):177-87. PubMed ID: 26618563
[TBL] [Abstract][Full Text] [Related]
32. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
33. Best practice in the treatment of advanced squamous cell lung cancer.
Ang YL; Tan HL; Soo RA
Ther Adv Respir Dis; 2015 Oct; 9(5):224-35. PubMed ID: 25902866
[TBL] [Abstract][Full Text] [Related]
34. Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
Balbin OA; Prensner JR; Sahu A; Yocum A; Shankar S; Malik R; Fermin D; Dhanasekaran SM; Chandler B; Thomas D; Beer DG; Cao X; Nesvizhskii AI; Chinnaiyan AM
Nat Commun; 2013; 4():2617. PubMed ID: 24135919
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer.
Kumar M; Ernani V; Owonikoko TK
Mol Aspects Med; 2015 Nov; 45():55-66. PubMed ID: 26187108
[TBL] [Abstract][Full Text] [Related]
36. Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout.
Favoni RE; Alama A
Drug Discov Today; 2013 Jan; 18(1-2):11-24. PubMed ID: 22885521
[TBL] [Abstract][Full Text] [Related]
37. A Potential Epigenetic Therapy for NSCLC.
Cancer Discov; 2015 Apr; 5(4):341. PubMed ID: 25724377
[TBL] [Abstract][Full Text] [Related]
38. What can be done for patients with NSCLC without druggable targets?
Besse B; Andre F; Soria JC
Lancet Oncol; 2013 Mar; 14(3):191-2. PubMed ID: 23452354
[No Abstract] [Full Text] [Related]
39. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.
Hanna N; Johnson D; Temin S; Masters G
J Oncol Pract; 2017 Dec; 13(12):832-837. PubMed ID: 28850309
[No Abstract] [Full Text] [Related]
40. [Research progress of targeted therapy in non-small cell lung cancer brain metastases].
Jiang T; Zhou C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):824-8. PubMed ID: 25404274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
